JPMorgan Chase & Co’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10
| Closed | -$20 | – | 6155 |
|
|
2025
Q1 | $20 | Sell |
10
-1
| -9% | -$2 | ﹤0.01% | 6245 |
|
|
2024
Q4 | $36 | Hold |
11
| – | – | ﹤0.01% | 6131 |
|
|
2024
Q3 | $30 | Sell |
11
-1
| -8% | -$3 | ﹤0.01% | 6126 |
|
|
2024
Q2 | $49 | Buy |
+12
| New | +$49 | ﹤0.01% | 6007 |
|
|
2024
Q1 | – | Sell |
-5
| Closed | -$24 | – | 6353 |
|
|
2023
Q4 | $24 | Buy |
5
+1
| +25% | +$5 | ﹤0.01% | 6273 |
|
|
2023
Q3 | $17 | Buy |
+4
| New | +$17 | ﹤0.01% | 6240 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5780 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5551 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5508 |
|
|
2022
Q2 | – | Sell |
-1,475
| Closed | -$55K | – | 5561 |
|
|
2022
Q1 | $55K | Sell |
1,475
-8,266
| -85% | -$308K | ﹤0.01% | 4981 |
|
|
2021
Q4 | $559K | Buy |
9,741
+442
| +5% | +$25.4K | ﹤0.01% | 3997 |
|
|
2021
Q3 | $951K | Buy |
9,299
+6,283
| +208% | +$643K | ﹤0.01% | 3640 |
|
|
2021
Q2 | $294K | Buy |
3,016
+2,188
| +264% | +$213K | ﹤0.01% | 4296 |
|
|
2021
Q1 | $85K | Buy |
828
+656
| +381% | +$67.3K | ﹤0.01% | 4685 |
|
|
2020
Q4 | $16K | Buy |
172
+38
| +28% | +$3.54K | ﹤0.01% | 4610 |
|
|
2020
Q3 | $61K | Buy |
134
+13
| +11% | +$5.92K | ﹤0.01% | 4232 |
|
|
2020
Q2 | $94K | Sell |
121
-34
| -22% | -$26.4K | ﹤0.01% | 3989 |
|
|
2020
Q1 | $108K | Buy |
155
+50
| +48% | +$34.8K | ﹤0.01% | 3915 |
|
|
2019
Q4 | $97K | Buy |
+105
| New | +$97K | ﹤0.01% | 4035 |
|